Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription 27.04.2026 1 Am J Kidney Dis 2 Ann Neurol 1 BMC Neurol 1 Brain 1 Curr Opin Immunol 1 Diabet Med 2 Diabetes 1 Intern Med 1 J Autoimmun 3 J Clin Endocrinol Metab 2 J Immunol 1 J Nephrol 1 J Neuroimmunol 3 J Neurol 1 J Pediatr Endocrinol Metab 2 Kidney Int 2 Lancet Neurol 4 Mult Scler 1 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Kidney Dis

1. ALMAANI S, Ayoub I, Geetha D
   KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis.
   Am J Kidney Dis. 2026;87:597-609.
   PubMed         Abstract available
   
   

   
   Ann Neurol

2. SCHNEIDER-HOHENDORF T, Eveslage M, Wirth T, Wunsch C, et al
   Confined B-Cell Reconstruction and High T-Cell Clonality Define Clinical Response to Cladribine Treatment.
   Ann Neurol. 2026;99:1166-1172.
   PubMed         Abstract available
   
   
3. PU YL, Feng JZ, Meng HX, Xiao HB, et al
   Myelitis-Predominant Aggressive Phenotype: Unveiling Unique Patterns of Late-Onset Neuromyelitis Optica Spectrum Disorders.
   Ann Neurol. 2026;99:1139-1151.
   PubMed         Abstract available
   
   

   
   BMC Neurol

4. ZHANG Y, Yao N, Yang J, Zou Y, et al
   Autoimmune nodopathy and focal segmental glomerulosclerosis mediated by anti-NF186 antibody: a case report and literature review.
   BMC Neurol. 2026 Apr 22. doi: 10.1186/s12883-026-04917.
   PubMed        
   
   

   
   Brain

5. SUICHI T, Misawa S, Ukita S, Shibuya K, et al
   The impact of the COVID-19 pandemic on the incidence and clinical profiles of Guillain-Barre syndrome in Japan.
   Brain. 2026 Apr 22:awag144. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Curr Opin Immunol

6. SEVIM E, Erton ZB, Erkan D
   Understanding antiphospholipid syndrome clinical phenotypes with the guidance of antiphospholipid antibody-related pathogenic mechanisms.
   Curr Opin Immunol. 2026;100:102770.
   PubMed         Abstract available
   
   

   
   Diabet Med

7. WYATT RC, Brigatti C, Grace SL, Williams CL, et al
   Improved prediction of symptomatic type 1 diabetes using a luciferase-based assay to measure (pro)insulin autoantibodies.
   Diabet Med. 2026 Apr 23:e70277. doi: 10.1111/dme.70277.
   PubMed         Abstract available
   
   

   
   Diabetes

8. DWYER JR, Racine JJ, Chapman HD, Bell A, et al
   Multiple Mechanisms Contribute to Robust Type 1 Diabetes Protection in Nfkbid- Overexpressing NOD Mice.
   Diabetes. 2026 Mar 20:db250956. doi: 10.2337/db25-0956.
   PubMed        
   
   
9. SAKAKI K, Murakami T, Yoshida H, Otani D, et al
   Quantitative beta-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes.
   Diabetes. 2026 Mar 12:db251127. doi: 10.2337/db25-1127.
   PubMed         Abstract available
   
   

   
   Intern Med

10. MORITA E, Harada K, Fujiwara T, Sato M, et al
    Fulminant Lupus Myocarditis as the Initial Manifestation of Systemic Lupus Erythematosus Successfully Treated with High-Dose Steroid Therapy: A Case Report.
    Intern Med. 2026 Apr 21. doi: 10.2169/internalmedicine.7074.
    PubMed         Abstract available
    
    

    
    J Autoimmun

11. MAKUS B, Schulze D, Lehnerer S, Gerischer L, et al
    Impact of a ketogenic diet on clinical outcomes and immunological markers in myasthenia gravis: A randomized pilot study.
    J Autoimmun. 2026;160:103562.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

12. REINHARDT C, Fotovat N, Siddiqui O, Ong J, et al
    Approach to the Patient: Therapeutic Mitigation of Lacrimal Manifestations in Thyroid Eye Disease.
    J Clin Endocrinol Metab. 2026 Feb 6:dgag045. doi: 10.1210.
    PubMed         Abstract available
    
    
13. DI CANDIA F, Rosanio FM, Franceschi R, Fierro A, et al
    Glucometabolic control and Anti-Transglutaminase Antibodies at Celiac Disease onset in Type 1 Diabetes youth.
    J Clin Endocrinol Metab. 2025 Nov 4:dgaf604. doi: 10.1210.
    PubMed         Abstract available
    
    
14. KONTOLA H, Crisostomo L, Loyttyniemi E, Koskenniemi JJ, et al
    Altered Glucagon Response to Oral Glucose in Individuals at Different Stages of Type 1 Diabetes Development.
    J Clin Endocrinol Metab. 2025 Oct 31:dgaf601. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Immunol

15. HORNICK EL, Oxley K, Debreceni IL, Wieting N, et al
    Syk inhibition limits autoimmunity and abnormal B cell phenotype and function in mice with B cell-specific TRAF3 deficiency.
    J Immunol. 2026;215:vkag049.
    PubMed         Abstract available
    
    
16. AL-HALLAF R, Agha Z, Caturegli P, Rosenberg A, et al
    Leveraging a naturally occurring IgM autoantibody to target diabetogenic T cells: a precision medicine approach to type 1 diabetes.
    J Immunol. 2026;215:vkag056.
    PubMed         Abstract available
    
    

    
    J Nephrol

17. DOS SANTOS BORGES R, Lara Santos R, Haikal de Paula L, Borges Martins JM, et al
    Efficacy, safety, and biomarker changes of B-cell activating factor and A proliferation-inducing ligand-targeted therapies in IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials.
    J Nephrol. 2026 Apr 22:aajaf002. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

18. MIGUET L, De Merlier M, Claeys KG
    Real-world evidence on utilization and clinical outcomes of efgartigimod in patients with generalized myasthenia gravis.
    J Neuroimmunol. 2026;417:578941.
    PubMed         Abstract available
    
    

    
    J Neurol

19. AVEDILLO-SALAS A, Martinez LB, Fanlo-Villacampa A, Vicente-Romero J, et al
    Efficacy and safety of monoclonal antibodies in the treatment of relapsing remitting multiple sclerosis: a systematic review.
    J Neurol. 2026;273:286.
    PubMed         Abstract available
    
    
20. BROCHARD V, Lecler A, Januel E, Chaugne E, et al
    Optic chiasmal neuritis: clinical features, aetiologies, MRI patterns and prognosis in a real-world cohort.
    J Neurol. 2026;273:282.
    PubMed         Abstract available
    
    
21. FUCHS TAN, Schoonheim MM, Strijbis EMM, Jelgerhuis JR, et al
    Predicting disease progression in multiple sclerosis with clinically accessible information and technology.
    J Neurol. 2026;273:281.
    PubMed         Abstract available
    
    

    
    J Pediatr Endocrinol Metab

22. KELLEHER JA, Kozak M, Sugiwaka H, Druskin Grimes LR, et al
    Family and culture in type 1 diabetes transition care: a mini review.
    J Pediatr Endocrinol Metab. 2026;39:315-323.
    PubMed         Abstract available
    
    

    
    Kidney Int

23. KURZHAGEN JT, Laqua W, Schett G, Grieshaber-Bouyer R, et al
    Tiny warriors, big impact: targeted immunotherapy in kidney diseases.
    Kidney Int. 2026;109:869-882.
    PubMed         Abstract available
    
    
24. PAUTRAT N, Raimbourg Q, Cohen C
    The Case | Febrile pancytopenia with mixed cryoglobulinemia and glomerulonephritis in a traveler.
    Kidney Int. 2026;109:1045-1046.
    PubMed        
    
    

    
    Lancet Neurol

25. GRUBER K
    Bruno Stankoff: advancing myelin repair in multiple sclerosis.
    Lancet Neurol. 2026;25:446.
    PubMed        
    
    
26. ATTFIELD KE, Armen AP, Kuttikkatte SB, Farooq R, et al
    Identification of genetic risk loci associated with aquaporin 4-positive neuromyelitis optica spectrum disorder: a genome-wide association study.
    Lancet Neurol. 2026;25:482-491.
    PubMed         Abstract available
    
    

    
    Mult Scler

27. BENVENISTE PL, Letourneau-Guillon L, Araujo D, Chougar L, et al
    Generalizable spinal cord multiple sclerosis lesion segmentation across MRI contrasts, protocols, and centers.
    Mult Scler. 2026 Apr 24:13524585261427333. doi: 10.1177/13524585261427333.
    PubMed         Abstract available
    
    
28. TOUBASI AA, Lakhani DA, Moore J, Schilling K, et al
    Spinal cord imaging in multiple sclerosis: A vital component we can no longer overlook.
    Mult Scler. 2026 Apr 21:13524585261438770. doi: 10.1177/13524585261438770.
    PubMed         Abstract available
    
    
29. TOLJAN K, Renner B, Daboul L, Martin ML, et al
    Diagnostic performance of central vein sign and paramagnetic rim lesion integration for multiple sclerosis.
    Mult Scler. 2026 Apr 20:13524585261434218. doi: 10.1177/13524585261434218.
    PubMed         Abstract available
    
    
30. FILIPPATOU AG, Sanjayan M, Dewey BE, Johnson E, et al
    Accelerometry-derived activity fragmentation as a predictor of brain atrophy and disability progression in multiple sclerosis.
    Mult Scler. 2026 Apr 20:13524585261435926. doi: 10.1177/13524585261435926.
    PubMed         Abstract available
    
    

    
    PLoS One

31. YTTERDAL M, Sandvik CE, Holmoy T, Bo L, et al
    The neural transdifferentiation potential of bone marrow mesenchymal stem cells.
    PLoS One. 2026;21:e0347119.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

32. ROY B, Obaid AH, Wang Z, Kovacs KG, et al
    Failure of early B cell tolerance and possible BCR signaling dysregulation underlie NF155-mediated autoimmune nodopathies.
    Proc Natl Acad Sci U S A. 2026;123:e2525717123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum